In this study, we aimed to explore the possible activity-dependent synaptic plasticity of NMDA receptors in CM, and our findings indicated that inhibition of NR2B-pTyr regulation of synaptic plasticity in central sensitization might be a novel and promising candidate for future treatment or prevention of CM. The gene discussed is GRIN2B; the disease is cutaneous mastocytosis.